Oral treatment with Gilenya (fingolimod) is more effective than Avonex (interferon beta-1a) for controlling brain…
Articles by Ana Pena PhD
Older age, a greater number of health conditions, and prior hospital admissions are associated with more hospitalizations due to all…
An investigational therapy that uses nanocrystals of gold to help the brain repair itself represents a breakthrough in the…
Starting treatment with a disease-modifying therapy (DMT) reduces blood levels of neurofilament light chain (NfL) — a potential biomarker of…
What science has told us about how diet might influence a person’s risk of multiple sclerosis and a patient’s…
Modulating the bacteria that reside in the gut by treating multiple sclerosis (MS) patients with probiotics, fecal transplants, or gut-related…
A signaling molecule of the immune system called interleukin 13 (IL-13) may modulate the function of key immune cells involved…
Ozanimod — an investigational oral therapy up for approval to treat relapsing multiple sclerosis (MS) — lowers…
CorTechs Labs presented new data indicating that machine learning models based on magnetic resonance imaging (MRI)…
Using a patient-friendly autoinjector pen to take monthly doses of ofatumumab — an investigational B-cell therapy…
A protein called dedicator of cytokinesis 8 (DOCK8) is key for the development and expansion of self-reactive immune T-cells that…
High-dose vitamin D supplements appear to aggravate inflammation and myelin loss in the brain and spinal cord,…
Clene Nanomedicine shared early results of the VISIONARY-MS trial, suggesting that CNM-Au8 — an…
Transplanting human glial progenitor cells (GPCs) — brain cells able to generate myelin-producing cells — effectively led to remyelination in…
Women with multiple sclerosis (MS) who have never given birth and those who began menopause prematurely tend to develop…
Using brain tissue from people with multiple sclerosis (MS) and mouse models of MS, scientists identified a key pathway…
First-line use of Genentech‘s Ocrevus (ocrelizumab) for patients with multiple sclerosis (MS) has remained stable through 2019…
Clene Nanomedicine‘s remyelination therapy candidate, CNM-Au8, showed a “robust” ability to stimulate the production of new myelin…
Immune cells have an inflammation ‘switch’ that involves the NLRP3 inflammasome pathway, and…
EyeStat, a portable device to measure blink reflex, has been cleared for use by the U.S. Food and…
Nerve impulses travel in a “dual cable” with myelin, playing additional roles to what was previously thought, new research…
Early research in animal models and human samples reveals how loss of communication between nerve cells contributes to the…
An ability to speak more than one language may help to protect people with multiple sclerosis (MS) against the…
Magenta Therapeutics will continue to advance its investigational conditioning therapy CD45-ADC for patients with autoimmune diseases undergoing stem cell…
Throughout 2019, Multiple Sclerosis News Today brought you daily coverage of the latest scientific findings, treatment developments, and clinical trials related…
Trials testing new immunotherapies for multiple sclerosis (MS) should focus more on patients’ experiences and on symptoms relevant…
Pear Therapeutics announced that a first patient is being treated in Part 2 of its feasibility trial of Pear-006,…
Processes related to metabolism in brain cells known as astrocytes may be at…
A small RNA molecule found in high levels in the gut of people with multiple sclerosis (MS) could…
Human herpesvirus 6A (HHV-6A), but not a widespread variant of the virus called HHV-6B, could be one of the…